VICTORIA – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE:TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that its subsidiary, Talem Therapeutics, entered into a collaboration with Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using […]
BEVERLY, Mass., and CANTON, Mass. — Sage Science, a developer of products for improving sample preparation processes in life science applications, and Universal Sequencing Technology today announced a distribution agreement to improve scientists’ access to long-range genomic information produced from short-read sequencing platforms. Through the agreement, Sage Science will distribute Universal Sequencing Technology’s TELL-Seq kits […]
OAKLAND, Calif.–In a step toward the full realization of genomic medicine, Fabric Genomics, a leader in AI-based genomic analysis and interpretation, has announced a co-marketing agreement that will provide translational researchers around the world with integrated sample prep to reporting workflows. Combining Roche’s newly released KAPA HyperExome Probes (RUO) with the Fabric Enterprise bioinformatics and […]
SAN FRANCISCO and MENLO PARK, Calif. — Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced a research collaboration focused on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic […]
SOUTH SAN FRANCISCO, Calif. — InterVenn, a San Francisco based biotechnology company innovating precision medicine and diagnostic products using next-generation mass spectrometry coupled to a proprietary artificial Intelligence/machine learning-based data processing engine, has announced a collaboration with Agilent Technologies, a leading provider of bio-analytical and scientific instrumentation. The signing of the collaboration took place on […]
Park Systems and Helmholtz Zentrum Berlin sign an agreement about a framework for joint research and development of metrology solutions for materials science We are particularly happy that with Park Systems we found a strong partner from industry who is known for their support of scientific research.” — Prof. Dr. Bernd Rech, Scientific Managing Director […]
Collaboration will utilize PacBio’s highly accurate HiFi sequencing to solve rare pediatric genetic diseases that have proven intractable in previous studies KANSAS CITY, Mo., and MENLO PARK, Calif. — Children’s Mercy Kansas City, one of the nation’s top pediatric medical systems, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of […]
ERS Genomics announces agreement with FASMAC to commercialize CRISPR/Cas9 research reagents in Japan
Food analysis and biotechnology company licenses gene editing technology Dublin, Ireland, and Kanagawa, Japan: ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with FASMAC Co., Ltd (“FASMAC”) of Japan. Under the terms of the […]
ST. LOUIS & NATICK, Mass. — PierianDx, the leading clinical genomics informatics company, and Pillar Biosciences, a leading next-generation sequencing clinical oncology company, today announced a partnership that enables Pillar Biosciences to sell directly the PierianDx clinical genomic report in combination with its cancer profiling assays. Under the agreement, PierianDx will integrate the Pillar Biosciences […]
Partnership Combines Twist’s Leadership in DNA Synthesis and Synthetic Biology with Neogene’s Expertise in Personalized Engineered T Cell Therapies SOUTH SAN FRANCISCO, Calif. & AMSTERDAM & NEW YORK–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Neogene Therapeutics, Inc., a biotechnology […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
